Aarey Drugs & Pharmaceuticals Limited — Board Meeting, 04-12-2024: Outcome of Board Meeting

The Board of Directors of Aarey Drugs and Pharmaceuticals Limited, in its recent meeting, approved the issuance of up to 50,00,000 warrants convertible into equity shares on a preferential basis, pending shareholder approval at the upcoming Extraordinary General Meeting (EGM) scheduled for January 2, 2025. Additionally, the Board has reappointed Mr. Lalit Radha Krishna Tulsiani and Mr. Anil Mandal as Independent Directors for five-year terms, subject to shareholder consent. The meeting highlighted strategic steps to facilitate growth through capital raising and governance enhancement.